We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+17.45%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$9.03B
AUM Growth
-$1.37B
Cap. Flow
-$2.48B
Cap. Flow %
-27.43%
Top 10 Hldgs %
18.31%
Holding
2,015
New
576
Increased
314
Reduced
307
Closed
636

Top Buys

Rank Stock Value
1
SKX
Skechers
SKX
+$18.3M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$17.4M
3
INSM icon
Insmed
INSM
+$16.1M
4
GILD icon
Gilead Sciences
GILD
+$15.8M
5
K
Kellanova
K
+$15.3M

Sector Composition

Rank Sector Weight
1 Healthcare 3.09%
2 Consumer Discretionary 2.5%
3 Technology 1.62%
4 Financials 1.05%
5 Communication Services 0.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMBL icon
1101
PUT
Bumble
BMBL
$372M
$521K 0.01%
+79,000
New +$399K
ALIT icon
1102
Alight
ALIT
$447M
$517K 0.01%
4,570
+1,445
+46% +$155K
OR icon
1103
CALL
OR Royalties Inc
OR
$5.58B
$514K 0.01%
20,000
AAOI icon
1104
CALL
Applied Optoelectronics
AAOI
$7.57B
$514K 0.01%
+20,000
New +$324K
AAOI icon
1105
PUT
Applied Optoelectronics
AAOI
$7.57B
$514K 0.01%
20,000
+10,000
+100% +$162K
IMVT icon
1106
Immunovant
IMVT
$7.93B
$513K 0.01%
+32,076
New +$485K
ALGM icon
1107
Allegro MicroSystems
ALGM
$7.73B
$513K 0.01%
15,000
+11,900
+384% +$296K
ARDX icon
1108
Ardelyx
ARDX
$1.22B
$512K 0.01%
+130,500
New +$538K
VRNA
1109
DELISTED
Verona Pharma
VRNA
$506K 0.01%
+5,351
New +$396K
BRSP
1110
CALL
BrightSpire Capital
BRSP
$634M
$505K 0.01%
+100,000
New +$505K
UTZ icon
1111
PUT
Utz Brands
UTZ
$1.25B
$501K 0.01%
39,900
RSKD icon
1112
PUT
Riskified
RSKD
$694M
$499K 0.01%
100,000
KRC icon
1113
Kilroy Realty
KRC
$4.52B
$496K 0.01%
14,443
-557
-4% -$18.2K
NUVL
1114
DELISTED
Nuvalent
NUVL
$491K 0.01%
+6,438
New +$471K
SNAP icon
1115
Snap
SNAP
$7.89B
$491K 0.01%
+56,500
New +$469K
FOA icon
1116
PUT
Finance of America Companies
FOA
$203M
$490K 0.01%
+21,000
New +$442K
ALKS icon
1117
PUT
Alkermes
ALKS
$8.22B
$486K 0.01%
17,000
-183,000
-92% -$5.45M
PFE icon
1118
CALL
Pfizer
PFE
$143B
$485K 0.01%
20,000
AGL icon
1119
Agilon Health
AGL
$1.53B
$483K 0.01%
8,400
SBLK icon
1120
PUT
Star Bulk Carriers
SBLK
$3.21B
$483K 0.01%
28,000
KROS icon
1121
Keros Therapeutics
KROS
$199M
$482K 0.01%
36,078
-70,903
-66% -$957K
RYTM icon
1122
Rhythm Pharmaceuticals
RYTM
$6.81B
$476K 0.01%
+7,540
New +$462K
OPFI.WS
1123
DELISTED
OppFi Inc Warrants
OPFI.WS
$475K 0.01%
+111,000
New +$337K
BRSL
1124
PUT
Brightstar Lottery PLC
BRSL
$1.84B
$474K 0.01%
30,000
-145,800
-83% -$2.29M
TGB
1125
CALL
Trekor Metals
TGB
$2.48B
$472K 0.01%
+149,800
New +$350K

Similar funds

Caption Management's Q2 2025 Portfolio in Review

As of Q2 2025, Caption Management held 2,015 positions worth $9.03B, down 13% from $10.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Caption Management withdrew a net $2.48B in Q2 2025, closing 636 positions and reducing 307 holdings. Its most notable exit was Microsoft, an estimated $394M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 1.5% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Caption Management opened a new position in Skechers worth $20.1M.

  • Caption Management's largest Q2 2025 buy was Skechers: 317,932 shares worth $20.1M.
  • Caption Management added most to Kellanova in Q2 2025, an estimated $15.3M increase.
  • Caption Management's biggest Q2 2025 reduction was Alphabet (Google) Class A, cutting an estimated $121M.
  • Caption Management fully exited Microsoft in Q2 2025, selling an estimated $394M.
  • Caption Management's ten largest holdings make up 18% of its $9.03B portfolio in Q2 2025.
  • Caption Management opened 576 new positions and closed 636 in Q2 2025.
  • Caption Management's portfolio value fell 13% quarter-over-quarter to $9.03B.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.